List Price Increase 'Incentives' Must Be Reversed, HHS Nominee Azar Says

Senate Finance Committee Democrats grill HHS Secretary nominee Alex Azar about his ability to foster solutions to high drug pricing given his industry background, as well as his support for alternative financing in Medicaid.